Home Cart Sign in  
Chemical Structure| 112901-68-5 Chemical Structure| 112901-68-5

Structure of Amifostine trihydrate
CAS No.: 112901-68-5

Chemical Structure| 112901-68-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Amifostine 3H2O is an approved radiation-protective agent and also a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents.

Synonyms: WR2721 trihydrate; Amifostine (hydrate); WR 2721

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Amifostine trihydrate

CAS No. :112901-68-5
Formula : C5H21N2O6PS
M.W : 268.27
SMILES Code : OP(O)(SCCNCCCN)=O.[H]O[H].[H]O[H].[H]O[H]
Synonyms :
WR2721 trihydrate; Amifostine (hydrate); WR 2721
MDL No. :MFCD00453866
InChI Key :TXQPXJKRNHJWAX-UHFFFAOYSA-N
Pubchem ID :148139

Safety of Amifostine trihydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Amifostine trihydrate (WR2721 trihydrate) is recognized for its broad-spectrum cytoprotective properties and serves as a radioprotector. It selectively shields normal tissues from the damaging effects of radiation and chemotherapy. Amifostine trihydrate acts as a potent inducer of hypoxia-inducible factor-α1 (HIF-α1) and p53, which are crucial for cellular protection. It also scavenges oxygen-derived free radicals, thereby safeguarding cells from oxidative damage. Moreover, Amifostine trihydrate is noted for reducing renal toxicity and exhibiting antiangiogenic effects[1].[2].[3].[4].

In Vitro:

Cell Line
Concentration Treated Time Description References
Murine fibroblast cell line L929 0.3 mg/mL 48 hours To evaluate the radioprotective effect of Amifostine on L929 cells, results showed that Amifostine effectively protected cells from lethal doses of X-ray radiation Nat Commun. 2020 Dec 4;11(1):6214.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Cisplatin-induced acute kidney injury model Intravenous injection 50 µg/200 µL Single dose, observed for 72 hours Evaluate the efficacy of Amifostine in preventing cisplatin-induced acute kidney injury. Results showed that Amifostine was ineffective at an equivalent dose. Adv Sci (Weinh). 2020 Apr 29;7(12):2000420
Zebra fish embryos Zebra fish embryo radioprotection model Immersion in culture medium 0.3 mg/mL Single administration, lasting 48 hours To evaluate the radioprotective effect of Amifostine on zebra fish embryos, results showed that Amifostine partially protected zebra fish embryos from lethal doses of X-ray radiation, but the effect was inferior to that of polymer P(2)(1) Nat Commun. 2020 Dec 4;11(1):6214.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.73mL

0.75mL

0.37mL

18.64mL

3.73mL

1.86mL

37.28mL

7.46mL

3.73mL

References

 

Historical Records